Grant is an M.D./M.B.A. student at Harvard Medical School and Harvard Business School, a researcher at Boston Children’s ...

Good afternoon, and welcome to the Travere Therapeutics Business Update Conference Call. Today's call is being recorded. At this time, I would like to turn the conference call over to Nivi Nehra, Vice ...

In a Phase III trial, Revolution Medicines' daraxonrasib almost doubled the survival length of people with advanced ...

Approximately 41,000 Americans live with a rare, genetic, degenerative disorder that is described as a combination of ALS, Alzheimer’s and Parkinson’s called Huntington’s Disease.

The Woburn-based biotech company cited a regulatory setback tied to its advanced skin cancer therapy as the reason for the ...

A newly approved obesity treatment faces additional regulatory review, highlighting ongoing evaluation of safety and ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today an invitation for U.S. based ...

Joint Jello Routine framework, ingredient research context, joint comfort and mobility formulation approach, and consumer ...

A 2026 program overview covering how Vital Step structures its doctor-prescribed compounded semaglutide and tirzepatide ...

Phage therapy is emerging as a potential solution to antibiotic resistance and superbugs, with clinical advances in ...

New research suggests GLP-1 drugs may improve liver and heart health even without major weight loss, reshaping how doctors ...

Eye rubbing is a common, often involuntary response to stimuli such as stress and fatigue as well as dermatologic and ...